Kelly Krogh, PhD, MBA

Strategic and science-driven medical affairs leader with a PhD in Pharmacology, an MBA from the Carlson School of Management, and public health training from Harvard. Combines deep scientific expertise with business acumen to guide field medical strategy, launch innovative therapeutics, and advance health outcomes. Recognized with 100+ industry awards for excellence, equity, and impact across Pfizer, Biogen, and Allergan. Builds trusted relationships with HCPs and internal stakeholders, translating complex data into actionable insights that drive performance, access, and patient care.

• Board Certified Medical Affairs Specialist (BCMAS), 2018, 2024

• 60+ Pfizer Bravo Awards (2023–2025), recognizing excellence, equity, and joy — some from senior executives including the Headquarters Medical Lead and Chief Commercial Officer.
• 30+ Biogen BIG Awards (2020–2022), acknowledging traits like agility, customer focus, inclusiveness, and accountability.
• 6 Allergan Awards (2018–2019), including “MSL of the Year” for the CNS/Psychiatry team.

• Member, Pfizer Colleague Advisory Board reporting into Aamir Malik. Part of Strategic Clarity Subgroup tasked with enhancing strategic clarity within the US Commerical Organization.
• Member, Pfizer Medical Colleague Advisory Board reporting into Terry Greising. Part of the Clarity Subgroup tasked with enhancing clarity around priorities and associated activities.
• Internal Medicine Field Medical Ambassador reporting into Tim Hylan
• Co-led Pfizer Field Medical Training, Certification, and onboarding resources for migraine team
• Designed and developed Biogen's "Find My MSL" initiative (company-wide rollout)
• Led cross-regional ARIA training initiative across US, EU, UAE, Latin America, and China medical affairs teams
• Created MSL Core Competency and Congress Repository at Allergan, adopted nationally